Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sanara MedTech Inc.SMTI · Entity 5880 | Pres. - Strat. Partnerships | December 02, 2022 | December 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sanara MedTech Inc.
Report date December 02, 2022 · Filed December 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,469 |
Ending reported balance
After 2022-12-02 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2022-12-02 · Tax withholding · Disposed 1,224 · Balance 17,326 F1: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Row 2 · 2022-12-02 · Tax withholding · Disposed 1,101 · Balance 16,225 F2: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Row 3 · 2022-12-02 · Tax withholding · Disposed 82 · Balance 16,143 F3: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Row 4 · 2022-12-02 · Tax withholding · Disposed 260 · Balance 15,883 F4: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Row 5 · 2022-12-02 · Disposition to issuer · Disposed 4,414 · Balance 11,469 F5: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
F2: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
F3: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
F4: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
F5: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 02, 2022 Filed Dec 6, 2022 23:33 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Disposition to issuerCommon Stock | 4,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 5 Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,469 F5 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022. F5 · price: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 23:33 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 260 | $22.97 | $5,972.20 |
DisclosureSEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 4 Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,883 F4 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F4 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 23:33 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 82 | $30.79 | $2,524.78 |
DisclosureSEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 3 Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,143 F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 23:33 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 1,101 | $36.86 | $40,582.86 |
DisclosureSEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 2 Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,225 F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 23:33 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 1,224 | $30.79 | $37,686.96 |
DisclosureSEC source: 0001493152-22-034632 · ownership.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · Pres. - Strat. Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,326 F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 21:00 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | SaleCommon Stock | 340 | $28.56 | $9,710.40 |
DisclosureSEC source: 0001493152-22-026823 · ownership.xml · nonDerivative · entry 2 Bowman Shawn M. · CIK 0001799604 · Pres. - Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,550 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.20 to $29.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 21:00 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | SaleCommon Stock | 660 | $27.54 | $18,176.40 |
DisclosureSEC source: 0001493152-22-026823 · ownership.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · Pres. - Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,890 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.185 to $28.10, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 20:15 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | SaleCommon Stock | 1,000 | $20.02 | $20,020.00 |
DisclosureSEC source: 0001493152-22-017378 · ownership.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · Pres. - Strategic Partnerships 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,550 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.50, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:53 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 2,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-006528 · ownership.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,550 F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2023, 2024 and 2025, respectively. F2 · balance_after: Reflects a correction to the amount of shares beneficially held, which amount, as provided in the Form 4 filed on December 27, 2021, reflected an inadvertent scrivener's error. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 21:30 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 3,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-032526 · ownership.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,226 F1 · shares: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three installments, with one-third of the shares vesting on February 1, 2022, and the remainder vesting in two equal installments on February 1, 2023 and 2024, respectively. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 21:15 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 196 | $35.53 | $6,963.88 |
DisclosureSEC source: 0001493152-21-032037 · ownership.xml · nonDerivative · entry 4 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,071 F4 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 801 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 802 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 21:15 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 196 | $45.67 | $8,951.32 |
DisclosureSEC source: 0001493152-21-032037 · ownership.xml · nonDerivative · entry 3 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,267 F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 802 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 333 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 21:15 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 82 | $45.67 | $3,744.94 |
DisclosureSEC source: 0001493152-21-032037 · ownership.xml · nonDerivative · entry 2 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,463 F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 333 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 333 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 21:15 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 123 | $45.67 | $5,617.41 |
DisclosureSEC source: 0001493152-21-032037 · ownership.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,545 F1 · shares: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 503 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 503 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| October 20, 2021 Filed Oct 21, 2021 20:35 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | SaleCommon Stock | 700 | $34.50 | $24,150.00 |
DisclosureSEC source: 0001654954-21-011258 · section16.xml · nonDerivative · entry 2 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,668 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| October 20, 2021 Filed Oct 21, 2021 20:35 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | SaleCommon Stock | 300 | $33.47 | $10,041.00 |
DisclosureSEC source: 0001654954-21-011258 · section16.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,368 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.32 to $33.56, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 21:09 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | SaleCommon Stock | 1,000 | $33.33 | $33,330.00 |
DisclosureSEC source: 0001654954-21-010616 · section16.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,668 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.15 to $33.41, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 22:40 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,603 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000097 · edgar.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,668 Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 19:55 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000064 · edgar.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,065 Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:27 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 13,555 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000059 · edgar.xml · nonDerivative · entry 3 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,065 Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:27 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000059 · edgar.xml · nonDerivative · entry 2 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,510 Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:27 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,510 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000059 · edgar.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,510 Read SEC document |
| February 24, 2020 Filed Sep 30, 2021 20:58 UTC Amendment | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 13,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010614 · section16.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,065 F1 · balance_after: On February 26, 2020, the reporting person filed a Form 4 (the "Original Form 4") which, among other things, inadvertently reported that the reporting person was awarded 1,000 shares of common stock of Sanara MedTech Inc. (the "Issuer"). The Original Form 4 is hereby being amended solely for the purpose of deleting the second line item that appeared in Table I of the Original Form 4 erroneously reporting that the reporting person was awarded 1,000 shares of common stock of the Issuer and amending Column 5 of the third line item of the Original Form 4 to reflect the actual number of shares beneficially owned by the reporting person following the reported transactions. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 15:07 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | OtherCommon Stock | 13,555 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897423-20-000045 · edgar.xml · nonDerivative · entry 3 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 13,555 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. F3 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 13,555 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 15:07 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | OtherCommon Stock | 1,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897423-20-000045 · edgar.xml · nonDerivative · entry 2 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,555 F2 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 1,000 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. F2 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 1,000 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 15:07 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | OtherCommon Stock | 1,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897423-20-000045 · edgar.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,555 F1 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 1,510 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. F1 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 1,510 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:42 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 13,555 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000017 · edgar.xml · nonDerivative · entry 3 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,065 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:42 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000017 · edgar.xml · nonDerivative · entry 2 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,510 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:42 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,510 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000017 · edgar.xml · nonDerivative · entry 1 Bowman Shawn M. · CIK 0001799604 · President - Wound Care Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,510 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.